Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add filters








Year range
1.
J. venom. anim. toxins incl. trop. dis ; 27: e20200073, 2021. tab, graf, ilus
Article in English | LILACS, VETINDEX | ID: biblio-1154769

ABSTRACT

he resistance against antimalarial drugs represents a global challenge in the fight and control of malaria. The Brazilian biodiversity can be an important tool for research and development of new medicinal products. In this context, toxinology is a multidisciplinary approach on the development of new drugs, including the isolation, purification, and evaluation of the pharmacological activities of natural toxins. The present study aimed to evaluate the cytotoxicity, as well as the antimalarial activity in silico and in vitro of four compounds isolated from Rhinella marina venom as potential oral drug prototypes. Methods: Four compounds were challenged against 35 target proteins from P. falciparum and screened to evaluate their physicochemical properties using docking assay in Brazilian Malaria Molecular Targets (BraMMT) software and in silico assay in OCTOPUS® software. The in vitro antimalarial activity of the compounds against the 3D7 Plasmodium falciparum clones were assessed using the SYBR Green I based assay (IC50). For the cytotoxic tests, the LD50 was determined in human pulmonary fibroblast cell line using the [3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT) assay. Results: All compounds presented a ligand-receptor interaction with ten Plasmodium falciparum-related protein targets, as well as antimalarial activity against chloroquine resistant strain (IC50 = 3.44 µM to 19.11 µM). Three of them (dehydrobufotenine, marinobufagin, and bufalin) showed adequate conditions for oral drug prototypes, with satisfactory prediction of absorption, permeability, and absence of toxicity. In the cell viability assay, only dehydrobufotenin was selective for the parasite. Conclusions: Dehydrobufotenin revealed to be a potential oral drug prototype presenting adequate antimalarial activity and absence of cytotoxicity, therefore should be subjected to further studies.(AU)


Subject(s)
Bufanolides/administration & dosage , Bufonidae , Biodiversity , Malaria/immunology , Antimalarials , In Vitro Techniques , Computer Simulation
2.
Acta amaz ; 49(2): 145-151, abr. - jun. 2019. tab
Article in English | LILACS, VETINDEX | ID: biblio-1119166

ABSTRACT

The skin secretion from toads of the Bufonidae family has great potential in the search for new active compounds to be used as drug candidates in treating some diseases, among them cancer. In this context, this study aimed to evaluate the cytotoxic and antimutagenic activity of the parotoid gland secretion extracts of Rhinella marina and Rhaebo guttatus, as well as biochemically analyze transaminases and serum creatinine for liver and renal damage, respectively. Cytotoxicity was performed by the colorimetric method based on MTT (3- [4, 5-dimethyl-2-thiazolyl]-2, 5-diphenyl-2H-tetrazolium bromide) with different concentrations of the extracts in Walker or splenic tumor cell cultures from rats and mice. The micronucleus test was performed with male Swiss mice treated orally with the extracts for 15 days, and then intraperitoneally with N-ethyl-N-nitrosurea (50 mg kg-1). Micronucleated polychromatic erythrocytes (MNPCE) were evaluated in bone marrow. The extracts showed cytotoxic activity in the evaluated cells. There was a significant reduction in the frequency of MNPCE (R. marina = 56% and R. guttatus = 75%, p < 0.001), indicating antimutagenic potential of the extracts. The groups treated only with extract showed an increase in MNPCE frequency, evidencing mutagenic potential. Biochemical analyzes showed no significant difference between treatments. Thus, under our experimental conditions, the extracts of R. marina and R. guttatus skin secretions presented chemopreventive potential for cancer. (AU)


A secreção cutânea de anuros da família Bufonidae tem grande potencial na busca de novos compostos ativos para utilização como fármacos candidatos no tratamento de algumas doenças, entre elas o câncer. Neste contexto, este estudo teve como objetivo avaliar a atividade citotóxica e antimutagênica dos extratos da secreção da glândula parótida de Rhinella marina e Rhaebo guttatus, bem como a análise bioquímica de transaminases e creatinina séricas, para avaliar dano hepático e renal, respectivamente. A avaliação de citotoxicidade foi realizada pelo método colorimétrico baseado no MTT (3-[4, 5-dimethyl-2-thiazolyl]-2, 5-diphenyl-2H-tetrazolium bromide), com diferentes concentrações dos extratos em culturas de células do Tumor de Walker ou células esplênicas de rato e camundongo. O teste do micronúcleo foi realizado com camundongos Swiss machos que receberam tratamento oral com os extratos durante 15 dias, seguido de tratamento intraperitoneal com N-etil-N-nitrosuréia (50 mg kg-1). A frequência de eritrócitos policromáticos micronucleados (PCEMN) foi determinada em medula óssea. Os extratos apresentaram ação citotóxica nas células avaliadas. Houve uma redução significativa na frequência de PCEMN (R. marina = 56% e R. guttatus = 75%, p < 0,001), observando-se um potencial antimutagênico dos extratos. Os grupos tratados somente com os extratos apresentaram um aumento na frequência de PCEMNs, evidenciando um potencial mutagênico. As análises bioquímicas não apresentaram diferença significativa entre os tratamentos. Assim, nas condições experimentais testadas, as secreções cutâneas de R. marina e R. guttatus apresentaram potencial quimiopreventivo para câncer.(AU)


Subject(s)
Animals , Mice , Bufonidae/physiology , Antimutagenic Agents/analysis , Cytotoxins/analysis , Parotid Gland/chemistry , Chemoprevention/veterinary , Bioprospecting
3.
Braz. J. Pharm. Sci. (Online) ; 55: e17754, 2019. tab, graf
Article in English | LILACS | ID: biblio-1039063

ABSTRACT

The study evaluated the vasorelaxant effect induced by the ethanolic extract of the leaves of Zanthoxylum rhoifolium Lam (EEtOH-Zr/leaves). Wistar rats were treated with the leaf extract containing a single dose of 2,000 mg / kg, v.o. After 14 days, the animals were anesthetized for blood collection and subsequent analysis of the biochemical parameters; they were then euthanized (sodium pentobarbital-100 mg/kg, i.p.) for the removal and morphological analysis of the heart, lung, liver and kidney. The vasorelaxation activity the and vascular reactivity of EEtOH-Zr/leaves were evaluated on artery mesenteric rings isolated from rats. The extract showed no signs of toxicity and no significant difference in the values of the biochemical parameters between the control group and the group of treated animals. In the evaluation of pharmacological activity in the smooth muscle, the EEtOH-Zr/leaves caused vasorelaxant effect on the tonic contraction induced by phenylephrine in mesenteric artery preparations in the presence (pD2=2.17±0.05 µg/mL; Emax=99.8±5.2%) and absence (pD2=2.14±0.05 µg/mL; Emax=95.3±6.4%) of the vascular endothelium. Oral administration of EEtOH-Zr/leaves reduced the contraction induced by the cumulative addition of PHE. It is concluded that the EEtOH-Zr/leaves promote vasorelaxation and reduce vascular reactivity of adrenergic alpha-1 agonist in the mesenteric artery. The results did not show toxic effects of the extract.


Subject(s)
Animals , Male , Rats , Plant Extracts/adverse effects , /analysis , Zanthoxylum/toxicity , Mesenteric Arteries/drug effects , Blood Vessels/drug effects
4.
Article in English | IMSEAR | ID: sea-176916

ABSTRACT

Phytochemical investigation of the ethanol extract of stem bark and leaves of Ximenia americana L. revealed the presence of epicatechin and quercetin, respectively. This is the first report of the occurrence of epicatechin in this genus. The extracts, fractions and isolated compounds of X. americana were subjected to an in vitro antioxidant activity assay by the DPPH method (2,2-diphenyl-1-picrylhydrazyl). The EC50 values were calculated and the results indicate that the ethyl acetate fractions of the stem bark and leaves have high antioxidant activity and a high content of total phenols. The high antioxidant activity of these fractions is justified by the presence of epicatechin and quercetin.

6.
Indian J Exp Biol ; 2013 Aug; 51(8): 661-669
Article in English | IMSEAR | ID: sea-149369

ABSTRACT

Administration of ethanol extract of stem bark from Z. rhoifolium (EEtOH-ZR) induced hypotension associated with a dual effect in heart rate in normotensive rats. This response was highlighted in spontaneously hypertensive rats (SHR). In rat superior mesenteric artery rings, the cumulative addition of EEtOH-ZR (0.1–750 µg/mL) on a phenylephrine-induced pre-contraction (10-5 M) promoted a vasorelaxant effect by a concentration-dependent manner and independent of vascular endothelium. A similar effect was obtained on KCl-induced pre-contractions (80 mM). EEtOH-ZR attenuated contractions induced by cumulative addition of CaCl2 (10-6–3 × 10-2 M) in depolarizing medium without Ca2+ only at 500 or 750 µg/mL. Likewise, on S-(–)-Bay K 8644-induced pre-contractions (10-7 M), the EEtOH-ZR-induced vasorelaxant effect was attenuated. EEtOH-ZR (27, 81, 243 or 500 µg/mL) inhibited contractions induced by cumulative addition of phenylephrine (10-9 - 10-5 M) in endothelium-denuded preparations or by a single concentration (10-5 M) in a Ca2+-free medium. The involvement of K+ channels was evaluated by tetraethylammonium (3 mM); the EEtOH-ZR-induced vasorelaxation was not attenuated. Thus, calcium influx blockade through voltage-operated calcium channels (CaVL) and inhibition of calcium release from intracellular stores are probably underlying EEtOH-ZR-induced cardiovascular effects.


Subject(s)
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester/pharmacology , Animals , Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Calcium Channel Agonists/pharmacology , Calcium Channels/drug effects , Calcium Chloride/pharmacology , Endothelium, Vascular/drug effects , Ethanol/chemistry , Male , Phenylephrine/pharmacology , Plant Bark/chemistry , Plant Stems/chemistry , Potassium Channels/drug effects , Potassium Chloride/pharmacology , Rats , Rats, Inbred SHR , Rats, Wistar , Vasoconstrictor Agents/pharmacology , Vasodilation/drug effects , Vasodilator Agents/pharmacology , Zanthoxylum/chemistry
7.
Acta amaz ; 40(1): 207-212, mar. 2010. ilus, graf
Article in Portuguese | LILACS, VETINDEX | ID: lil-546976

ABSTRACT

A investigação fitoquímica das cascas do caule de Sterculia striata St. Hil. et Naudin, através de métodos cromatográficos, conduziu ao isolamento dos esteróides sitosterol, estigmasterol e sitosterol-3-O-ß-D-glicopiranosídeo, além de quatro triterpenóides pentacíclicos, o lupeol, 3-ß-O-acil lupeol, lupenona e ácido betulínico. As estruturas desses compostos foram identificadas por análise dos espectros de RMN ¹H e 13C e comparações com dados da literatura. Para determinação do teor de fenóis totais do extrato etanólico de S. striata utilizou-se o reativo Folin Ciocalteu, enquanto na avaliação da atividade antioxidante empregou-se o radical livre DPPH. Este é o primeiro trabalho descrevendo o estudo químico com as cascas do caule desta espécie.


The phytochemical investigation of the stem bark of Sterculia striata St. Hil. et Naudin by chromatographic methods led to the isolation of sitosterol, stigmasterol and sitosterol-3-O-ß-D-glucopyranoside, besides pentacyclic triterpenoids, lupeol, 3-ß-O-acyl-lupeol, lupenone and betulinic acid. The structures of these compounds were identified by ¹H and 13C NMR spectral data analysis and comparison with literature data. For determining of the phenolic content of the etanolic extract of Sterculia striata we used the Folin Ciocalteu reagent, and for the evaluation of antioxidant activity, we utilized the DPPH free radical. This is the first work reporting the chemical study with the stem bark of this species.


Subject(s)
Sitosterols/chemistry , Stigmasterol/chemistry , Triterpenes , Sterculia/chemistry , Antioxidants/analysis
SELECTION OF CITATIONS
SEARCH DETAIL